Platform - Ligand Binding Assays
Ligand Binding Assays continue to be the primary tool used in the biopharmaceutical sciences to quantitate proteins and anti-drug antibodies in biological fluids and tissues. This assay platform is a useful tool used from early drug discovery, through pre-clinical toxicology work, and clinical studies.
KCAS has grown to meet the LBA demands of the industry
The Ligand Binding Assay (LBA) team at KCAS is growing to meet changes for support of bioanalytical biopharmaceuticals and biomarker testing. The areas we are seeing the biggest need for growth is in the areas of Immuno-Oncology therapies, cell & gene therapies, monoclonal antibodies and Antibody Drug Conjugates (ADCs). To meet the needs of our customers in this area, our LBA team has more than doubled its size in our new facility.